Sara Sanz Rojo

Prof. Dr. Sara Sanz Rojo

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JZJose Javier Zamorano-Leon
Jose Javier Zamorano-Leon
RGRodrigo Jiménez Garcia
Rodrigo Jiménez Garcia
Ana Lopez-de-AndresAna Lopez-de-Andres
Ana Lopez-de-Andres
JMJavier de Miguel-Díez
Javier de Miguel-Díez
David Carabantes-AlarcónDavid Carabantes-Alarcón
David Carabantes-Alarcón
SRSara Sanz Rojo
Sara Sanz Rojo
(1) Background: In this work, we aim to describe influenza vaccine uptake among the diabetic population in Spain to assess the time trend from 2011 to 2020 and identify predictors of vaccine uptake among diabetes patients. (2) Methods: We conducted a descriptive cross-sectional study using the European Health Interview Survey for Spain (2014 and 2020) and the Spanish National Health Surveys (2011 and 2017). The independent variables analysed included socio-demographic characteristics, health-related variables and lifestyle variables. We matched each participant with diabetes with a non-diabetic participant based on age, sex, place of residence and year of survey. (3) Results: The overall coverage among diabetic adults was 52.1% compared to 40.6% for matched participants without diabetes (p < 0.01). The vaccine uptake among adults with diabetes was 52.6% in 2011, 54.38% in 2014 and 53.4% in 2017. The adjusted OR of having been vaccinated in 2020, with respect to 2011, was not significant at 0.87 (95% CI: 0.72–1.06). Factors such as being male, higher age, being affected by respiratory disease or cancer and being physically active were identified as positive predictors for influenza vaccination uptake, while smoking was a negative predictor. (4) Conclusions: The influenza vaccine uptake is below desirable levels among the adult diabetic population in Spain and has not improved from 2011 to 2020. More efforts should be made to increase influenza vaccine uptake in this high-risk group, especially for women, those aged 18–64 years, without other high-risk conditions and smokers.

19 June 2018 in American Journal of Alzheimer's Disease and Other Dementias®
Verified
Journal Article
Open access
IMIsmael San Mauro Martín
Ismael San Mauro Martín
VBVíctor Paredes Barato
Víctor Paredes Barato
SOSara López Oliva
Sara López Oliva
MRMarta Rodríguez
Marta Rodríguez
LYLUIS Collado Yurrita
LUIS Collado Yurrita
EVElena Garicano Vilar
Elena Garicano Vilar
Observe the association of foods habits, body composition, lifestyle habits, and loss of gustatory function with Alzheimer’s disease (AD). This comparative study enrolled 75 patients with AD (mean age 77.5 years) and 267 healthy volunteers (mean age 73 years). Weight, height, body mass index (BMI), body fat, visceral fat, muscle mass, and waist circumference were measured. Adherence to the Mediterranean diet was measured by the Mediterranean-Diet-Adherence Screener. Gustatory function was investigated using a threshold and triangle test. Cases with AD presented lower BMI and weight and higher sleep hours, being statistically significant the difference between cases and controls (P = .02; P = .001; P = .001, respectively). Patients with AD showed lower adherence to exercise and Mediterranean diet as shown by the Mediterranean Diet Adherence Screener–score (8.12 ± 2.5 vs 8.65 ± 2.4). The gustatory function was impaired in patients with AD when compared to controls. Patients with AD show worst outcomes in terms of anthropometric measurements, lifestyle habits (diet, exercise), and gustatory function than controls.

3 September 2019 in Nutritional Neuroscience
Verified
Journal Article
Closed access
IMIsmael San Mauro Martin
Ismael San Mauro Martin
SRSara Sanz Rojo
Sara Sanz Rojo
EVElena Garicano Vilar
Elena Garicano Vilar
LCLourdes González Cosano
Lourdes González Cosano
RCRaquel Conty de la Campa
Raquel Conty de la Campa
JOJavier Andres Blumenfeld Olivares
Javier Andres Blumenfeld Olivares
Background: The aetiology of Attention Deficit Hyperactivity Disorder (ADHD) continues to be debated, although several contributing factors have been acknowledged. Objective: Assess the association between weight, birth attributes, exercise and sleep habits, dietary intake and adherence to a Mediterranean diet, and impulsive behaviour on Spanish ADHD children. Establish whether specific food groups (not just adherence to the Mediterranean diet) associate with impulsive behaviour. Methods: This observational cross-sectional study included 57 ADHD children from Madrid (Spain). Demographic, clinical data, sleep, exercise and technology-use habits were obtained. Anthropometric measurements included height and weight. Adherence to the Mediterranean diet was assessed using the KIDMED test. Barratt Impulsivity Scale version-11c was used to assess impulsivity. Subjects were divided into three groups for analysis, according to their age (6–10 years, children; 11–13 years, pre-adolescents; 14–16 years, adolescents). Results: There were clear associations between those who had higher BIS scores and who slept less at weekends (49.4 ± 10.16 vs. 43.8 ± 12.51), who adhered poorly to the Mediterranean diet (49.9 ± 11.72 vs. 41.6 ± 16.52), who used internet and technological devices for >3 h/day (45.5 ± 13.6 vs. 44.7 ± 12.11), who were born with >2.5 kg (46.1 ± 11.61 vs. 42.9 ± 15.29), who were delivered by caesarean (45.1 ± 12.78 vs. 44.7 ± 12.5) and who were not breastfed (45.0 ± 13.38 vs. 44.8 ± 12.39). Subjects exercising more than 3 days a week also scored slightly higher (45.4±14.02 vs. 44.6±11.85) in the BIS. Conclusion: There is a need to follow up the link between ADHD and sleep onset difficulties, dietary patterns, technological habits, perinatal factors, breastfeeding and birth delivery mode.

20 April 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
IMIsmael San Mauro Martin
Ismael San Mauro Martin
SOSara López Oliva
Sara López Oliva
EVElena Garicano Vilar
Elena Garicano Vilar
GNGuerthy Melissa Sánchez Niño
Guerthy Melissa Sánchez Niño
BPBruno F. Penadés
Bruno F. Penadés
LYLUIS Collado Yurrita
LUIS Collado Yurrita
As gluten may trigger gastrointestinal disorders (GIDs), its presence or absence in the diet can change the diversity and proportion of gut microbiota. The effects of gluten after six weeks of a double-blind, placebo-controlled intervention with a gluten-free diet (GFD) were studied in participants with GIDs suffering from migraines and atopic dermatitis (n = 46). Clinical biomarkers, digestive symptoms, stool, the Migraine Disability Assessment questionnaire, and zonulin levels were analyzed. Next-generation sequencing was used to amplify the 16S rRNA gene of bacteria and the internal transcribed spacer (ITS) regions of fungi. The GFD increased Chao1 fungal diversity after the intervention, while the fungal composition showed no changes. Bacterial diversity and composition remained stable, but a positive association between bacterial and fungal Chao1 diversity and a negative association between Dothideomycetes and Akkermansia were observed. GIDs decreased in both groups and migraines improved in the placebo group. Our findings may aid the development of GID treatment strategies.

1 November 2021 in Vaccine
Verified
Journal Article
Closed access
SRSara Sanz Rojo
Sara Sanz Rojo
RGRodrigo Jiménez Garcia
Rodrigo Jiménez Garcia
ALAna López-De-Andrés
Ana López-De-Andrés
JMJavier de Miguel-Diez
Javier de Miguel-Diez
NPNapoleón Perez-Farinos
Napoleón Perez-Farinos
JZJosé J. Zamorano-León
José J. Zamorano-León

28 September 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
EVElena Garicano Vilar
Elena Garicano Vilar
SOSara López Oliva
Sara López Oliva
BPBruno F. Penadés
Bruno F. Penadés
GNGuerthy Melissa Sánchez Niño
Guerthy Melissa Sánchez Niño
ALAna Terrén Lora
Ana Terrén Lora
IMIsmael San Mauro Martin
Ismael San Mauro Martin
The Mediterranean diet (MD) has beneficial effects on the intestinal microbiota by the promotion of bacteria associated with a healthy gut. However, its impact on intestinal fungi, among others, is still unknown, and how it affects digestive symptoms and different biomarkers in patients with gastrointestinal (GI) disorders has hardly been explored. The present study evaluated the effect of the MD on gut microbial diversity and structure and intestinal symptoms and biomarkers after 6 weeks of dietary intervention in 46 patients with GI disorders. Dysbiosis in fungal composition and diversity was observed, with a significantly lower abundance of Sordariomycetes, Leotiomycetes, and Orbiliomycetes; a significantly higher abundance of Saccharomycetes; the Chytridiomycota and Mucoromycota phyla were significantly reduced; and the bacterial microbiota remained unchanged. In addition, various GI disorders decreased and associations between stool consistency and intestinal permeability were found with the bacterial genera Alistipes and Roseburia. Thus, the data suggest that MD can alter the fungal intestinal microbiota and improve GI disorders.